GlaxoSmithKline Pharmaceuticals (BOM:500660) Days Sales Outstanding : 22.08 (As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Days Sales Outstanding?

GlaxoSmithKline Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was ₹2,221 Mil. GlaxoSmithKline Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was ₹9,179 Mil. Hence, GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 22.08.

The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

BOM:500660' s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.57 Med: 19.85 Max: 23.53
Current: 22.11

During the past 13 years, GlaxoSmithKline Pharmaceuticals's highest Days Sales Outstanding was 23.53. The lowest was 12.57. And the median was 19.85.

BOM:500660's Days Sales Outstanding is ranked better than
92.36% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs BOM:500660: 22.11

GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding declined from Mar. 2023 (23.03) to Mar. 2024 (22.08).

GlaxoSmithKline Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Days Sales Outstanding Chart

GlaxoSmithKline Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

12.57

19.85

23.53

22.49

21.98

GlaxoSmithKline Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															23.03	23.05	20.13	23.92	22.08

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding falls into.

GlaxoSmithKline Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1923.75	+	2220.571)	/	2 )	/	34417.708	*	365
=	2072.1605					/	34417.708	*	365
=	21.98

GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	2220.571)	/	1 )	/	9178.608	*	365 / 4
=	2220.571					/	9178.608	*	365 / 4
=	22.08

GlaxoSmithKline Pharmaceuticals (BOM:500660) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

GlaxoSmithKline Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

GLAXO:India

Address

Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030

Website

https://www.gsk-india.com

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines